Caspase 8 inhibits programmed necrosis by processing CYLD
Marie Anne O’Donnell, Eva Pérez-Jiménez, Andrew Oberst et al. · Nature Cell Biology · 2011
Cited by 492 works. doi:10.1038/ncb2362
Authors
- Marie Anne O’Donnell
- Eva Pérez-Jiménez
- Andrew Oberst
- Aylwin Ng
- Ramin Massoumi
- Ramnik J. Xavier
- Douglas R. Green
- Adrian T. Ting
References
- A gene atlas of the mouse and human protein-encoding transcriptomes
- Java Treeview—extensible visualization of microarray data
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
- Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
- Activation of IKK by TNFα Requires Site-Specific Ubiquitination of RIP1 and Polyubiquitin Binding by NEMO